Published in Antiviral Res on January 18, 2010
Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J Biol Chem (2011) 1.16
Filoviruses utilize glycosaminoglycans for their attachment to target cells. J Virol (2013) 1.11
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses. Antimicrob Agents Chemother (2010) 0.93
A novel dendrimeric peptide with antimicrobial properties: structure-function analysis of SB056. Biophys J (2012) 0.90
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. Antimicrob Agents Chemother (2012) 0.90
Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob Agents Chemother (2011) 0.88
Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm (2012) 0.87
The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J Virol (2012) 0.85
A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. Antimicrob Agents Chemother (2013) 0.82
Dendrimers functionalized with membrane-interacting peptides for viral inhibition. Int J Nanomedicine (2013) 0.82
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. PLoS One (2013) 0.82
Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus. Antimicrob Agents Chemother (2010) 0.79
Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases. Indian J Virol (2013) 0.76
Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues. J Virol (2016) 0.76
Antiviral activity of a Bacillus sp. P34 peptide against pathogenic viruses of domestic animals. Braz J Microbiol (2014) 0.76
Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications. Int J Mol Sci (2017) 0.75
The human cytomegalovirus. Pharmacol Ther (2003) 2.06
The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog (2012) 1.64
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol (2004) 1.50
Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol (2013) 1.38
Protein and peptide arrays: recent trends and new directions. Biomol Eng (2006) 1.34
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem (2007) 1.23
Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann N Y Acad Sci (2007) 1.21
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol (2007) 1.18
A late complication of pelvic radiotherapy: leiomyosarcoma of the rectum. Report of a case and review of the literature. Hepatogastroenterology (2003) 1.09
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother (2005) 1.06
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells. J Leukoc Biol (2005) 1.06
A new polymeric coating for protein microarrays. Anal Biochem (2004) 1.04
Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell Microbiol (2007) 1.03
Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J Virol (2002) 1.03
The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity (2010) 1.02
High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol (2008) 1.02
Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts. J Gen Virol (2002) 0.97
Evaluation of six methods for extraction and purification of viral DNA from urine and serum samples. New Microbiol (2006) 0.95
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16. Arthritis Rheum (2006) 0.95
Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Antiviral Res (2006) 0.95
Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. J Virol (2004) 0.94
Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. Antimicrob Agents Chemother (2008) 0.94
Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients. J Clin Virol (2003) 0.94
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses. Antimicrob Agents Chemother (2010) 0.93
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response. Eur J Immunol (2010) 0.93
Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interferon Cytokine Res (2002) 0.93
Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression. New Microbiol (2006) 0.92
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides. Pharmacol Ther (2009) 0.92
The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology. J Interferon Cytokine Res (2011) 0.92
A novel dendrimeric peptide with antimicrobial properties: structure-function analysis of SB056. Biophys J (2012) 0.90
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. Antimicrob Agents Chemother (2012) 0.90
Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus. Antimicrob Agents Chemother (2008) 0.89
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding. PLoS One (2013) 0.89
Pherogram normalization in capillary electrophoresis and micellar electrokinetic chromatography analyses in cases of sample matrix-induced migration time shifts. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.89
Antimicrobial peptides: the LPS connection. Methods Mol Biol (2010) 0.88
Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob Agents Chemother (2011) 0.88
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. J Pept Sci (2007) 0.87
Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship. Mediators Inflamm (2012) 0.87
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck (2009) 0.86
Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha. Cell Immunol (2009) 0.86
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. Rheumatology (Oxford) (2010) 0.86
Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties. Peptides (2010) 0.86
Evidence that the human cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. Virology (2004) 0.86
Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology (2012) 0.86
Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? Clin Gastroenterol Hepatol (2005) 0.85
The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J Virol (2012) 0.85
Atomic force microscopy evaluation of the effects of a novel antimicrobial multimeric peptide on Pseudomonas aeruginosa. Nanomedicine (2007) 0.85
CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol (2005) 0.85
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. J Autoimmun (2010) 0.85
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein. Antimicrob Agents Chemother (2010) 0.85
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp Cell Res (2004) 0.84
Strategies for the construction and use of peptide and antibody libraries displayed on phages. Curr Protein Pept Sci (2004) 0.84
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis. New Microbiol (2014) 0.84
Postherpetic paresis mimicking an abdominal herniation. Acta Derm Venereol (2006) 0.84
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiol (2013) 0.83
Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage. Virus Res (2006) 0.83
Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene. J Invest Dermatol (2011) 0.83
The oxygenase component of phenol hydroxylase from Acinetobacter radioresistens S13. Eur J Biochem (2003) 0.82
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. PLoS One (2013) 0.82
Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnol (2008) 0.82
Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. Cancer Res (2010) 0.81
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. Histopathology (2009) 0.81
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells. J Gen Virol (2003) 0.81
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response. New Microbiol (2015) 0.81
Surface behavior and molecular recognition in DNA microarrays from N,N-dimethylacrylamide terpolymers with activated esters as linking groups. Macromol Biosci (2006) 0.81
Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment. ChemMedChem (2013) 0.81
The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication. Virology (2006) 0.81
A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity. FASEB J (2005) 0.81
Synthesis of Weinreb amides via Pd-catalyzed aminocarbonylation of heterocyclic-derived triflates. J Org Chem (2008) 0.81
Cloning and characterization of two catechol 1,2-dioxygenase genes from Acinetobacter radioresistens S13. Res Microbiol (2002) 0.81
Fine-tuning of catalytic properties of catechol 1,2-dioxygenase by active site tailoring. Chembiochem (2009) 0.81